Benjamin Kramer Selected Research

indacaterol

2/2014	Effect of once-daily indacaterol in a predominantly Chinese population with chronic obstructive pulmonary disease: a 26-week Asia-Pacific study.
12/2012	Efficacy of indacaterol 75 μg once-daily on dyspnea and health status: results of two double-blind, placebo-controlled 12-week studies.
12/2012	Assessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian population.
9/2012	Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.
2/2012	Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: a 12-week, placebo-controlled study.
12/2011	Efficacy of indacaterol in the treatment of patients with COPD.
12/2011	Efficacy and tolerability of indacaterol 75 μg once daily in patients aged ≥40 years with chronic obstructive pulmonary disease: results from 2 double-blind, placebo-controlled 12-week studies.
10/2011	Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease.
7/2011	Effect of indacaterol on exercise endurance and lung hyperinflation in COPD.
7/2011	Long-term safety and efficacy of indacaterol, a long-acting β₂-agonist, in subjects with COPD: a randomized, placebo-controlled study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin Kramer Research Topics

Disease

24	Chronic Obstructive Pulmonary Disease (COPD) 02/2014 - 03/2010
4	Seasonal Allergic Rhinitis (Hay Fever) 07/2005 - 11/2002
3	Dyspnea (Shortness of Breath) 02/2014 - 12/2012
2	Body Weight (Weight, Body) 01/2021 - 12/2018
2	Non-alcoholic Fatty Liver Disease 12/2018 - 04/2018
2	Insulin Resistance 12/2018 - 04/2018
2	Cough 09/2012 - 03/2010
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	COVID-19 01/2021
1	Ascites 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2018
1	Hypertension (High Blood Pressure) 12/2018
1	Glucose Intolerance 12/2018
1	Hypoxia (Hypoxemia) 04/2018
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2018
1	Headache (Headaches) 01/2011
1	Nasopharyngitis 01/2011
1	Asthma (Bronchial Asthma) 11/2010
1	Rhinorrhea 07/2005
1	Sneezing 07/2005
1	Sleepiness 07/2005

Drug/Important Bio-Agent (IBA)

24	indacaterolIBA 02/2014 - 03/2010
12	Bronchodilator Agents (Bronchodilators)IBA 09/2012 - 06/2010
5	Tiotropium Bromide (Spiriva)FDA Link 09/2012 - 07/2010
5	Salmeterol Xinafoate (Serevent)FDA Link 12/2011 - 09/2010
4	Cetirizine (Zyrtec)FDA LinkGeneric 07/2005 - 11/2002
3	Formoterol Fumarate (Oxis)FDA Link 12/2011 - 06/2010
2	CholesterolIBA 12/2018 - 04/2018
2	Triglycerides (Triacylglycerol)IBA 12/2018 - 04/2018
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2011 - 11/2010
2	Albuterol (Salbutamol)FDA LinkGeneric 07/2011 - 09/2010
2	fexofenadine (Allegra)FDA LinkGeneric 07/2005 - 01/2004
1	Lysine (L-Lysine)FDA Link 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2021
1	NK Cell Lectin-Like Receptor Subfamily KIBA 01/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	Interleukin-18 (Interleukin 18)IBA 01/2019
1	NK Cell Lectin-Like Receptor Subfamily CIBA 01/2019
1	InterferonsIBA 01/2019
1	CarbohydratesIBA 12/2018
1	Nonesterified Fatty Acids (NEFA)IBA 12/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2018
1	Toll-Like Receptor 4IBA 12/2018
1	AdiponectinIBA 12/2018
1	Ellagic AcidIBA 04/2018
1	PolyphenolsIBA 04/2018
1	Transcription Factors (Transcription Factor)IBA 04/2018
1	AntioxidantsIBA 04/2018
1	Blood Glucose (Blood Sugar)IBA 04/2018
1	GoldIBA 12/2012
1	N 556IBA 01/2011
1	Fluticasone (Cutivate)FDA LinkGeneric 09/2010

Therapy/Procedure

2	Dry Powder Inhalers 01/2011 - 09/2010
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Catheters 01/2018
1	Therapeutics 12/2011
1	Nebulizers and Vaporizers (Inhaler) 01/2011